Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft vs Host Disease | 9 | 2017 | 3049 | 1.040 |
Why?
|
Stem Cell Transplantation | 3 | 2015 | 1596 | 0.670 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2019 | 5717 | 0.610 |
Why?
|
Transplantation Conditioning | 3 | 2019 | 1601 | 0.590 |
Why?
|
Galactosylceramides | 1 | 2017 | 90 | 0.540 |
Why?
|
Intestinal Diseases | 2 | 2012 | 505 | 0.530 |
Why?
|
Busulfan | 2 | 2015 | 259 | 0.510 |
Why?
|
Vidarabine | 2 | 2015 | 337 | 0.500 |
Why?
|
Lymphoma | 2 | 2015 | 1898 | 0.460 |
Why?
|
Transplantation, Homologous | 5 | 2017 | 4833 | 0.450 |
Why?
|
Elafin | 1 | 2012 | 30 | 0.410 |
Why?
|
Integrin alpha4 | 1 | 2012 | 88 | 0.410 |
Why?
|
Sirolimus | 2 | 2017 | 1540 | 0.410 |
Why?
|
Integrin beta Chains | 1 | 2012 | 115 | 0.400 |
Why?
|
Myeloablative Agonists | 1 | 2013 | 210 | 0.400 |
Why?
|
Niacinamide | 1 | 2014 | 418 | 0.400 |
Why?
|
Respirovirus Infections | 1 | 2011 | 51 | 0.390 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 661 | 0.390 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2013 | 263 | 0.380 |
Why?
|
Phenylurea Compounds | 1 | 2014 | 531 | 0.370 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2017 | 3114 | 0.360 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 494 | 0.360 |
Why?
|
Hematologic Neoplasms | 2 | 2019 | 1907 | 0.320 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2011 | 305 | 0.320 |
Why?
|
Lectins, C-Type | 1 | 2012 | 594 | 0.320 |
Why?
|
Immunologic Memory | 2 | 2012 | 1377 | 0.310 |
Why?
|
Bone Marrow Transplantation | 1 | 2017 | 2709 | 0.310 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2012 | 4648 | 0.310 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2014 | 3626 | 0.290 |
Why?
|
Flow Cytometry | 3 | 2012 | 5902 | 0.280 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2496 | 0.270 |
Why?
|
HLA Antigens | 1 | 2011 | 1334 | 0.260 |
Why?
|
Interleukin-2 | 1 | 2012 | 1895 | 0.250 |
Why?
|
Integrins | 1 | 2009 | 842 | 0.240 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 1997 | 0.230 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4262 | 0.220 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 1399 | 0.210 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3740 | 0.210 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 1560 | 0.200 |
Why?
|
Acute Disease | 4 | 2017 | 7243 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 11878 | 0.190 |
Why?
|
T-Lymphocyte Subsets | 1 | 2009 | 1815 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.180 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1437 | 0.170 |
Why?
|
Antiviral Agents | 1 | 2011 | 3073 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5703 | 0.150 |
Why?
|
Ikaros Transcription Factor | 1 | 2017 | 233 | 0.120 |
Why?
|
Survival Rate | 3 | 2015 | 12840 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11928 | 0.120 |
Why?
|
Disease-Free Survival | 2 | 2015 | 6847 | 0.120 |
Why?
|
Natural Killer T-Cells | 1 | 2017 | 318 | 0.110 |
Why?
|
Drug Synergism | 1 | 2017 | 1760 | 0.100 |
Why?
|
Parainfluenza Virus 3, Human | 1 | 2011 | 25 | 0.100 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10266 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9419 | 0.100 |
Why?
|
Tacrolimus | 1 | 2015 | 750 | 0.090 |
Why?
|
Middle Aged | 9 | 2019 | 223492 | 0.090 |
Why?
|
Solubility | 1 | 2012 | 1083 | 0.090 |
Why?
|
Histocompatibility Testing | 1 | 2011 | 716 | 0.080 |
Why?
|
Aged | 7 | 2019 | 171504 | 0.080 |
Why?
|
Survival Analysis | 2 | 2013 | 10101 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1625 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13676 | 0.080 |
Why?
|
Remission Induction | 1 | 2014 | 2410 | 0.080 |
Why?
|
Methotrexate | 1 | 2015 | 1721 | 0.080 |
Why?
|
Nasopharynx | 1 | 2011 | 420 | 0.080 |
Why?
|
Administration, Inhalation | 1 | 2011 | 1169 | 0.080 |
Why?
|
Antigens, Surface | 1 | 2012 | 1617 | 0.070 |
Why?
|
Vincristine | 1 | 2010 | 1040 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 696 | 0.070 |
Why?
|
Respiratory Function Tests | 1 | 2011 | 1695 | 0.070 |
Why?
|
Adult | 6 | 2019 | 223646 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2011 | 863 | 0.060 |
Why?
|
Female | 9 | 2019 | 397192 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8741 | 0.060 |
Why?
|
Prednisone | 1 | 2010 | 1567 | 0.060 |
Why?
|
Male | 8 | 2019 | 364719 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2120 | 0.060 |
Why?
|
Humans | 12 | 2019 | 768166 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2227 | 0.060 |
Why?
|
Skin Diseases | 1 | 2012 | 1085 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2661 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2862 | 0.050 |
Why?
|
Doxorubicin | 1 | 2010 | 2234 | 0.050 |
Why?
|
Intestines | 1 | 2012 | 1909 | 0.050 |
Why?
|
Young Adult | 3 | 2017 | 60066 | 0.050 |
Why?
|
Viral Load | 1 | 2011 | 3396 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2013 | 81762 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10474 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2013 | 65371 | 0.040 |
Why?
|
Biopsy | 1 | 2012 | 6793 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4146 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 4415 | 0.040 |
Why?
|
Oxygen | 1 | 2011 | 4270 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8509 | 0.040 |
Why?
|
Proteomics | 1 | 2012 | 3912 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15832 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9384 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11095 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39348 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9263 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2009 | 22291 | 0.020 |
Why?
|
Cohort Studies | 1 | 2010 | 41754 | 0.020 |
Why?
|
Adolescent | 1 | 2010 | 89169 | 0.010 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_